Dong-E-E-Jiao Co., Ltd. (SHE:000423)
China · Delayed Price · Currency is CNY 55.61
+0.29 (0.52%)
Apr 8, 2026, 2:05 PM CST
Dong-E-E-Jiao Revenue
In the year 2025, Dong-E-E-Jiao had annual revenue of 6.70B CNY with 8.83% growth. Dong-E-E-Jiao had revenue of 1.93B in the quarter ending December 31, 2025, with 21.52% growth.
Revenue
6.70B
Revenue Growth
+8.83%
P/S Ratio
5.30
Revenue / Employee
1.54M
Employees
4,345
Market Cap
35.53B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 6.70B | 543.77M | 8.83% |
| Dec 31, 2024 | 6.16B | 1.44B | 30.57% |
| Dec 31, 2023 | 4.72B | 673.45M | 16.66% |
| Jan 1, 2023 | 4.04B | 192.83M | 5.01% |
| Jan 1, 2022 | 3.85B | 439.55M | 12.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Sanjiu Medical & Pharmaceutical | 31.60B |
| Humanwell Healthcare (Group) | 23.96B |
| Beijing Tongrentang | 17.26B |
| Changchun High-Tech Industry (Group) | 12.88B |
| Livzon Pharmaceutical Group | 12.02B |
| Hubei Jumpcan Pharmaceutical | 6.14B |
| Shijiazhuang Yiling Pharmaceutical | 6.01B |
| Kangmei Pharmaceutical | 5.28B |